Wockhardt announces successful initiation of Global Phase 3 Clinical Study of its novel antibiotic WCK 5222
WCK 5222 is a Super-drug which is entirely a new class of antibiotic known as "?-lactam ENHANCER".
WCK 5222 is a Super-drug which is entirely a new class of antibiotic known as "?-lactam ENHANCER".
Subscribe To Our Newsletter & Stay Updated